StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Dermapharm Holding SE
XETRA:DMP.DE
Sector
Location
Market Cap
USD 2.24 B
Share Price
USD 41.43
Avg Daily Volume
27,081
Change (1 day)
-0.02%
Change (1 year)
6.16%
Change (YTD)
2.35%
Dermapharm Holding SE Total Assets for the year ending December 31, 2024: USD 2.15 B
Dermapharm Holding SE Total Assets is USD 2.15 B for the year ending December 31, 2024, a -9.69% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Dermapharm Holding SE Total Assets for the year ending December 31, 2023 was USD 2.38 B, a 57.76% change year over year.
-
Dermapharm Holding SE Total Assets for the year ending December 31, 2022 was USD 1.51 B, a -5.62% change year over year.
-
Dermapharm Holding SE Total Assets for the year ending December 31, 2021 was USD 1.60 B, a 7.08% change year over year.
-
Dermapharm Holding SE Total Assets for the year ending December 31, 2020 was USD 1.50 B, a 27.55% change year over year.
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
Divi's Laboratories Limited
USD 80.79
DIVISLAB.NS
+0.31
0.38%
ALK-Abelló A/S
USD 29.89
ALK-B.CO
+0.58
1.96%
Nahdi Medical Company
USD 34.75
4164.SR
+0.54
1.56%
Hypera S.A.
USD 5.10
HYPE3.SA
+0.02
0.45%
Rohto Pharmaceutical Co.,Ltd.
USD 14.31
4527.T
+0.07
0.50%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.16
JBCHEPHARM.NS
-0.03
-0.14%
Almirall, S.A.
USD 12.66
ALM.MC
+0.18
1.44%
Organon & Co.
USD 9.96
OGN
-0.19
-1.87%
Caplin Point Laboratories Limited
USD 23.60
CAPLIPOINT.NS
+0.17
0.71%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
Divi's Laboratories Limited
USD 80.79
DIVISLAB.NS
+0.31
0.38%
ALK-Abelló A/S
USD 29.89
ALK-B.CO
+0.58
1.96%
Nahdi Medical Company
USD 34.75
4164.SR
+0.54
1.56%
Hypera S.A.
USD 5.10
HYPE3.SA
+0.02
0.45%
Rohto Pharmaceutical Co.,Ltd.
USD 14.31
4527.T
+0.07
0.50%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.16
JBCHEPHARM.NS
-0.03
-0.14%
Almirall, S.A.
USD 12.66
ALM.MC
+0.18
1.44%
Organon & Co.
USD 9.96
OGN
-0.19
-1.87%
Caplin Point Laboratories Limited
USD 23.60
CAPLIPOINT.NS
+0.17
0.71%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%